Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
desktop_windows
CDK4 and other advances in hormone positive cancers
Professor Richard Simcock | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
desktop_windows
Compliance with adjuvant endocrine therapy and management of side effects
Ann Partridge | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Supporting women with adherence to endocrine therapy
Linda Sharp & Eila Watson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
menu_book
Radiotherapy omission is considered in women >70 years old with ER+ T1N0 tumour post-BCS if the patient receives endocrine therapy (ET). However, the impact of poor adherence to ET on locoregional rec...
Regina Matar MD et al | Annals of Surgical Oncology
24.04.2022 | Added: 24.04.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Management of the older patient
menu_bookPublication menu_book -
menu_book
This EBCTCG meta-analysis investigated whether pre-menopausal women treated with ovarian suppression benefited from aromatase inhibitors (AIs). Meta-analysis was performed from individual patient data...
n/a | National Library of Medicine
23.03.2022 | Added: 23.03.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
list
Updated recommendations regarding the management of older patients with breast cancer
The European Society of Breast Cancer Specialists (EUSOMA) and The International Society of Geriatric Oncology (SIOG) have produced a useful document outlining the evidence based management of older p...
European Society of Breast Cancer Specialists (EUSOMA) & International Society of Geriatric Oncology (SIOG) | Italy & France
21.08.2021 | Added: 21.08.2021
Classifications: Breast Cancer Treatment
Keywords: Management of the older patient
listGuideline list -
menu_book
Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer
This prospective randomised trial assigned postmenopausal women with HR-positive breast cancer who had received 5 years of adjuvant endocrine therapy (n=3484) to receive either additional 2 or 5 years...
Michael Gnant et al | The New England Journal of Medicine
28.07.2021 | Added: 28.07.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
desktop_windows
Neoadjuvant Endocrine Treatment
ABS | ABS Conference 2021
17.05.2021 | Added: 17.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
menu_book
This was a multicentre, prospective, observational cohort study of surgery or primary endocrine therapy in women aged over 70 years with operable breast cancer (n=3416 with 56 UK breast units who part...
J L M Morgan et al | British Journal of Surgery
24.03.2021 | Added: 24.03.2021
Classifications: Breast Cancer Treatment
Keywords: Management of the older patient
menu_bookPublication menu_book -
list
Endocrine treatment for breast cancer
ABS have produced an up to date guideline on endocrine therapy for early breast cancer patients
Association of Breast Surgery, UK
21.01.2021 | Added: 21.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
listGuideline list -
Oncology update on adjuvant extended endocrine treatment and adjuvant bisphosphonates
Dr Catherine Harper-Wynne | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Bisphosphonates
-
desktop_windows
Enhancing response to neoadjuvant Letrozole: The PALLET trial
Prof Stephen Johnston | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Trials
desktop_windowsWebcast desktop_windows -
list
Early and locally advanced breast cancer: diagnosis and treatment
NICE have updated their guidance on the management of early breast cancer to take into account developments since the 2009 iteration of this guidance. They recommend re-excision of breast tissue shoul...
National Institute for Health and Care Excellence (NICE), UK | United Kingdom
18.08.2018 | Added: 18.08.2018
Classifications: Breast Cancer Treatment Service Guidance
Keywords: Early Breast Cancer Locally Advanced Breast Cancer
listGuideline list -
desktop_windows
Ms Shelley Potter | ABS Conference 2018
18.06.2018 | Added: 18.06.2018
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Neoadjuvant endocrine therapy; effect on phenotype and molecular profile in luminal breast carcinoma
Nahla Badr | ABS Conference 2018
18.06.2018 | Added: 18.06.2018
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Mr Robert Thomas | ABS Conference 2017
15.05.2017 | Added: 15.05.2017
Classifications: Adjuvant & Neoadjuvant Treatment
desktop_windowsWebcast desktop_windows -
desktop_windows
Should all hormone receptor positive breast cancer patients be offered extended endocrine therapy?
Prof John Benson | ABS Conference 2017
15.05.2017 | Added: 15.05.2017
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows
